Pages with the fewest revisions

Jump to navigation Jump to search

Showing below up to 50 results in range #10,881 to #10,930.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. Nephrotic syndrome MRI (1 revision)
  2. Nephrotic syndrome and risk of venous and arterial thromboembolism (1 revision)
  3. Nephrotome (1 revision)
  4. Nerelimomab (1 revision)
  5. Nerisopam (1 revision)
  6. Nerol (1 revision)
  7. Neroli (1 revision)
  8. Nerve (1 revision)
  9. Nerve conduction study (1 revision)
  10. Nerve growth factor IB (1 revision)
  11. Nerve injury (1 revision)
  12. Nerve of pterygoid canal (1 revision)
  13. Nerve root (1 revision)
  14. Nerve to the stapedius (1 revision)
  15. Nerve to the subclavius (1 revision)
  16. Nervous system (1 revision)
  17. Nervous system disease (1 revision)
  18. Nervous tissue (1 revision)
  19. Nervus intermedius (1 revision)
  20. Net clinical benefit (1 revision)
  21. Netherlands Forensic Institute (1 revision)
  22. Netherton's syndrome (1 revision)
  23. Netrin G1 (1 revision)
  24. Netrin G2 (1 revision)
  25. Nettle (1 revision)
  26. Neural Fibrolipoma (1 revision)
  27. Neural backpropagation (1 revision)
  28. Neural crest (1 revision)
  29. Neural development (1 revision)
  30. Neural development in humans (1 revision)
  31. Neuralgia CT (1 revision)
  32. Neuralgia MRI (1 revision)
  33. Neuralgia case study one (1 revision)
  34. Neuralgia classification (1 revision)
  35. Neuralgia cost-effectiveness of therapy (1 revision)
  36. Neuralgia differential diagnosis (1 revision)
  37. Neuralgia future or investigational therapies (1 revision)
  38. Neuralgia historical perspective (1 revision)
  39. Neuralgia history and symptoms (1 revision)
  40. Neuralgia other imaging findings (1 revision)
  41. Neuralgia pathophysiology (1 revision)
  42. Neuralgia physical examination (1 revision)
  43. Neuralgia primary prevention (1 revision)
  44. Neuralgia screening (1 revision)
  45. Neuralgia secondary prevention (1 revision)
  46. Neuralized e3 ubiquitin protein ligase 3 (1 revision)
  47. Neurally mediated syncope (1 revision)
  48. Neuraminic acid (1 revision)
  49. Neuraminidase inhibitor (1 revision)
  50. Neuraxial blockade (1 revision)

View ( | ) (20 | 50 | 100 | 250 | 500)